Reducing prostaglandin E2 production to raise cancer immunogenicity.pdf (1.16 MB)
Reducing prostaglandin E2 production to raise cancer immunogenicity
journal contributionposted on 2021-08-18, 11:43 authored by Santiago Zelenay, Caetano Reis e Sousa
Cyclooxygenases (COX), commonly upregulated in numerous cancers, generate prostaglandin E2 (PGE2), which has been implicated in key aspects of malignant growth including proliferation, invasion and angiogenesis. Recently, we showed that production of PGE2 by cancer cells dominantly enables progressive tumor growth via immune escape and that cyclooxygenase inhibitors synergize with immunotherapy to enhance tumor eradication.